Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2296 AL 2310

Xanthone: Potential Acetylcholinesterase Inhibitor for Alzheimer's Disease Treatment

Vanessa VV, Mah SH.

Mini Rev Med Chem. 2021;21(17):2507-2529. doi: 10.2174/1389557521666210212152514.

Home-based multimodal exercise program in older people with Alzheimer disease: Randomized controlled trial protocol

Cezar NOC, Ansai JH, de Andrade LP.

Physiother Res Int. 2021 Apr;26(2):e1899. doi: 10.1002/pri.1899. Epub 2021 Feb 15.

Discovery of Atabecestat (JNJ-54861911): A Thiazine-Based β-Amyloid Precursor Protein Cleaving Enzyme 1 Inhibitor Advanced to the Phase 2b/3 EARLY Clinical Trial

Koriyama Y, Hori A, Ito H, Yonezawa S, Baba Y, Tanimoto N, Ueno T, Yamamoto S, Yamamoto T, Asada N, Morimoto K, Einaru S, Sakai K, Kanazu T, Matsuda A, Yamaguchi Y, Oguma T, Timmers M, Tritsmans L, Kusakabe KI, Kato A, Sakaguchi G.

J Med Chem. 2021 Feb 25;64(4):1873-1888. doi: 10.1021/acs.jmedchem.0c01917. Epub 2021 Feb 15.

Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review

Ahmad SS, Khalid M, Kamal MA, Younis K.

Curr Neuropharmacol. 2021;19(11):1884-1895. doi: 10.2174/1570159X19666210215122333.

Recent Multi-target Approaches on the Development of Anti- Alzheimer's Agents Integrating Metal Chelation Activity

Chaves S, Várnagy K, Santos MA.

Curr Med Chem. 2021;28(35):7247-7277. doi: 10.2174/0929867328666210218183032.

Exploring new avenues for modifying course of progression of Alzheimer's disease: The rise of natural medicine

Lye S, Aust CE, Griffiths LR, Fernandez F.

J Neurol Sci. 2021 Mar 15;422:117332. doi: 10.1016/j.jns.2021.117332. Epub 2021 Jan 30.

Exploring the multifunctional role of melatonin in regulating autophagy and sleep to mitigate Alzheimer's disease neuropathology

Hossain MF, Wang N, Chen R, Li S, Roy J, Uddin MG, Li Z, Lim LW, Song YQ.

Ageing Res Rev. 2021 May;67:101304. doi: 10.1016/j.arr.2021.101304. Epub 2021 Feb 18.

Clinical Approach of Low-Dose Whole-Brain Ionizing Radiation Treatment in Alzheimer's Disease Dementia Patients

Chung M, Rhee HY, Chung WK.

J Alzheimers Dis. 2021;80(3):941-947. doi: 10.3233/JAD-210042.

Intranasal drug delivery for treatment of Alzheimer's disease

Fonseca LC, Lopes JA, Vieira J, Viegas C, Oliveira CS, Hartmann RP, Fonte P.

Drug Deliv Transl Res. 2021 Apr;11(2):411-425. doi: 10.1007/s13346-021-00940-7. Epub 2021 Feb 26.

Low Doses of Ionizing Radiation as a Treatment for Alzheimer's Disease: A Pilot Study

Cuttler JM, Abdellah E, Goldberg Y, Al-Shamaa S, Symons SP, Black SE, Freedman M.

J Alzheimers Dis. 2021;80(3):1119-1128. doi: 10.3233/JAD-200620.

Natural Products Targeting Amyloid Beta in Alzheimer's Disease

Lee JH, Ahn NH, Choi SB, Kwon Y, Yang SH.

Int J Mol Sci. 2021 Feb 26;22(5):2341. doi: 10.3390/ijms22052341.

Accelerating Alzheimer's disease drug discovery and development: what's the way forward?

Imbimbo BP, Ippati S, Watling M, Balducci C.

Expert Opin Drug Discov. 2021 Jul;16(7):727-735. doi: 10.1080/17460441.2021.1887132. Epub 2021 Mar 2.

In Quest of Tablet Apps for Elders With Alzheimer's Disease: A Descriptive Review

Tak SH.

Comput Inform Nurs. 2021 Mar 3;39(7):347-354. doi: 10.1097/CIN.0000000000000718.

A review on ferulic acid and analogs based scaffolds for the management of Alzheimer's disease

Singh YP, Rai H, Singh G, Singh GK, Mishra S, Kumar S, Srikrishna S, Modi G.

Eur J Med Chem. 2021 Apr 5;215:113278. doi: 10.1016/j.ejmech.2021.113278. Epub 2021 Feb 15.

Acetylcholinesterase Inhibitory Potential of Various Sesquiterpene Analogues for Alzheimer's Disease Therapy

Arya A, Chahal R, Rao R, Rahman MH, Kaushik D, Akhtar MF, Saleem A, Khalifa SMA, El-Seedi HR, Kamel M, Albadrani GM, Abdel-Daim MM, Mittal V.

Biomolecules. 2021 Feb 25;11(3):350. doi: 10.3390/biom11030350.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias